Published on GHDx (https://ghdx.healthdata.org)

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

General Info

Geography 
Canada (CAN)
United States of America (USA)
Coverage type 
Country
Time period covered 
January, 2001 - June, 2009
Data type
Scientific literature
Keywords 
Blood glucose

Citation

Authors 
Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group
Journal 
Lancet
Pages 
419-30
Publication year 
2010
Suggested citation 
Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010; 3776(9739): 419-30.
Source URL:https://ghdx.healthdata.org/record/effect-intensive-treatment-hyperglycaemia-microvascular-outcomes-type-2-diabetes-analysis